Pancreatic Cancer Research

ResearcherHarvard UniversityActive in the last 2 years

Yoshifumi Noda

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3611-4790; OpenAlex author ID A5000428996, A5123924473. Sources: OpenAlex.

Their work

Papers
24 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
31
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: 2 papers · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: 3 papers · 2023: 4 papers · 2024: 4 papers · 2025: none · 2026: 4 papers

Papers 24

  1. Impact of image reconstruction algorithms on histogram analysis of iodine concentration for assessing chemotherapy response in pancreatic ductal adenocarcinoma. First author DOI 10.1007/s00261-026-05671-2↗
  2. Novel silicon-based material decomposition images in diagnosis of pancreatic ductal adenocarcinoma: comparison with iodine-based and 50-keV virtual monoenerget… Co-author DOI 10.1007/s11604-025-01856-9↗
  3. Characteristics of ill-demarcated small pancreatic ductal adenocarcinoma on MRI: a multi-institutional retrospective cohort study. Co-author DOI 10.1007/s11604-026-02003-8↗
  4. Pancreatic Cancer Screening and Early Detection: Current Strategies and Emerging Innovations in Imaging. Co-author DOI 10.1016/j.rcl.2026.01.005↗
  5. Pancreatic cancer detection with dual-energy CT: diagnostic performance of 40 keV and 70 keV virtual monoenergetic images. Co-author DOI 10.1007/s11547-024-01806-x↗
  6. Effect of X-ray tube on image quality and pancreatic ductal adenocarcinoma conspicuity in pancreatic protocol dual-energy CT. Co-author DOI 10.1016/j.crad.2023.12.024↗
  7. Does CT overestimate extra-pancreatic perineural invasion in patients with pancreatic ductal adenocarcinoma following neoadjuvant chemoradiation therapy? Co-author DOI 10.1093/bjr/tqae001↗
  8. Assessment of Arterial Involvement in Pancreatic Cancer: Utility of Reconstructed CT Images Perpendicular to Artery. Co-author DOI 10.3390/cancers16122271↗
  9. Determination of arterial invasion in pancreatic ductal adenocarcinoma: what is the best diagnostic criterion on CT? Co-author DOI 10.1007/s00330-023-09521-3↗
  10. Comparison of image quality and pancreatic ductal adenocarcinoma conspicuity between the low-kVp and dual-energy CT reconstructed with deep-learning image reco… Co-author DOI 10.1016/j.ejrad.2022.110685↗
  11. Deep-learning image reconstruction for 80-kVp pancreatic CT protocol: Comparison of image quality and pancreatic ductal adenocarcinoma visibility with hybrid-i… First author DOI 10.1016/j.ejrad.2023.110960↗
  12. MRI-Based Tumor Necrosis Depiction in Pancreatic Ductal Adenocarcinoma: Can It Predict Tumor Aggressiveness? Co-author DOI 10.3390/cancers15082313↗
  13. Vascular involvement and resectability of pancreatic ductal adenocarcinoma on contrast-enhanced MRI: comparison with pancreatic protocol CT. Co-author DOI 10.1007/s00261-022-03581-7↗
  14. Arterial involvement and resectability scoring system to predict R0 resection in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemor… Co-author DOI 10.1007/s00330-021-08304-y↗
  15. Prediction of overall survival in patients with pancreatic ductal adenocarcinoma: histogram analysis of ADC value and correlation with pathological intratumora… Co-author DOI 10.1186/s12880-022-00751-3↗
  16. Simulated twin-phase pancreatic CT generated using single portal venous phase dual-energy CT acquisition in pancreatic ductal adenocarcinoma. Co-author DOI 10.1007/s00261-020-02921-9↗
  17. Hepatobiliary contrast uptake patterns on gadoxetic acid-enhanced MRI in liver metastases from pancreatic ductal adenocarcinoma: can it predict prognosis? Co-author DOI 10.1007/s00330-020-07115-x↗
  18. Detection of pancreatic ductal adenocarcinoma and liver metastases: comparison of Gd-EOB-DTPA-enhanced MR imaging vs. extracellular contrast materials. Co-author DOI 10.1007/s00261-020-02511-9↗
  19. Virtual monochromatic image at lower energy level for assessing pancreatic ductal adenocarcinoma in fast kV-switching dual-energy CT. Co-author DOI 10.1016/j.crad.2019.11.012↗
  20. Pancreatic MRI associated with pancreatic fibrosis and postoperative fistula: comparison between pancreatic cancer and non-pancreatic cancer tissue. Co-author DOI 10.1016/j.crad.2019.02.013↗
  21. Prognostic evaluation of pancreatic ductal adenocarcinoma: Associations between molecular biomarkers and CT imaging findings. Co-author DOI 10.1016/j.pan.2019.01.016↗
  22. Modified National Comprehensive Cancer Network Criteria for Assessing Resectability of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.2214/ajr.17.18595↗
  23. Assessing Chemotherapeutic Response in Pancreatic Ductal Adenocarcinoma: Histogram Analysis of Iodine Concentration and CT Number in Single-Source Dual-Energy … Co-author DOI 10.2214/ajr.18.19791↗
  24. Determination of the least amount of iodine load required for the detection of pancreatic adenocarcinoma at 80-kVp CT. Co-author DOI 10.1016/j.ejrad.2016.02.014↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masayuki Matsuo · 17 shared papers, 2016–2026 · strength 2.57
  2. Avinash R. Kambadakone · 11 shared papers, 2021–2026 · strength 2.20
  3. Yukiko Takai · 7 shared papers, 2020–2026 · strength 1.38
  4. Satoshi Goshima · 8 shared papers, 2016–2026 · strength 0.93
  5. Masashi Asano · 4 shared papers, 2023–2026 · strength 0.87
  6. Shravya Srinivas Rao · 2 shared papers, 2024–2026 · strength 0.60
  7. Anushri Parakh · 3 shared papers, 2021–2024 · strength 0.56
  8. Vinit Baliyan · 2 shared papers, 2021–2023 · strength 0.37
  9. Michael Hayden Rosenthal · 1 shared paper, 2026 · strength 0.36
  10. Khoschy Schawkat · 1 shared paper, 2026 · strength 0.36
  11. Theodore Sunki Hong · 2 shared papers, 2022–2023 · strength 0.32
  12. Keitaro Sofue · 1 shared paper, 2026 · strength 0.26
  13. Yoshihiko Fukukura · 1 shared paper, 2026 · strength 0.26
  14. Yoshiki Asayama · 1 shared paper, 2026 · strength 0.26
  15. Nobuhiro Fujita · 1 shared paper, 2026 · strength 0.26
  16. Dai Inoue · 1 shared paper, 2026 · strength 0.26
  17. Shogo Takeuchi · 1 shared paper, 2026 · strength 0.26
  18. Mari A. Mino-Kenudson · 1 shared paper, 2024 · strength 0.24
  19. Mark Anderson · 1 shared paper, 2023 · strength 0.19
  20. Nobuhisa Matsuhashi · 1 shared paper, 2024 · strength 0.17
  21. Kazuhiro Yoshida · 1 shared paper, 2024 · strength 0.17
  22. Masahiro Fukada · 1 shared paper, 2024 · strength 0.17
  23. Kyongtae T. Bae · 2 shared papers, 2016–2018 · strength 0.15
  24. Yurie Sekigami · 1 shared paper, 2022 · strength 0.13
  25. Carlos F. Fernandez-del Castillo · 1 shared paper, 2022 · strength 0.13

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.